A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus
Surveyed dermatologists and rheumatologists differed in their experience with quinacrine for CLE and SLE, respectively. Availability remains a key barrier to prescribing, underscoring the need to address supply issues and conduct further research to optimize quinacrine use in SLE and CLE.
Authors
- Zahi Touma (ORCID: https://orcid.org/0000-0001-5177-2076)
- Wendy Singer
- Victoria P. Werth (ORCID: https://orcid.org/0000-0003-3030-5369)
- Arielle Mendel (ORCID: https://orcid.org/0000-0001-9732-616X)
- Sasha Bernatsky (ORCID: https://orcid.org/0000-0002-9515-2802)
- Daniel F. Wallace (ORCID: https://orcid.org/0000-0002-6019-9424)
- Évelyne Vinet (ORCID: https://orcid.org/0000-0001-7727-5879)
- John A. Reynolds (ORCID: https://orcid.org/0000-0002-8962-4404)
- Paul R. Fortin (ORCID: https://orcid.org/0000-0002-7278-2596)
- Sarah Aly (ORCID: https://orcid.org/0000-0001-5873-1576)
- Carter Thorne
- Nathalie Costedoat-Chalumeau
- Gilda Parastandehchehr
Institutions
- Cedars-Sinai Medical Center (US)
- University Health Network (CA)
- Inserm (FR)
- Université du Québec à Montréal (CA)
- University of California, Los Angeles (US)
- University of Toronto (CA)
- Université Paris Cité (FR)
- McGill University Health Centre (CA)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Philadelphia VA Medical Center (US)
- Arthritis Research Centre of Canada (CA)
- Centre for Inflammation Research (GB)
- McGill University (CA)
- Université de Strasbourg (FR)
- Singer (United States) (US)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3899/jrheum.2025-0757
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00